tiprankstipranks
Core Scientific Inc (CORZ)
NASDAQ:CORZ
US Market

Core Scientific Inc (CORZ) Income Statement

90 Followers

Core Scientific Inc Income Statement

Last quarter (Q4 2023), Core Scientific Inc's total revenue was $141.93M, a decrease of -62.72% from the same quarter last year. In Q4, Core Scientific Inc's net income was $-184.40M. See Core Scientific Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21
Total Revenue
$ 502.40M$ 502.40M$ 640.31M$ 544.48M
Cost of Revenue
--$ 631.91M$ 305.62M
Gross Profit
$ 502.40M$ 502.40M$ 8.40M$ 238.86M
Operating Expense
$ 397.61M$ 487.56M$ 242.59M$ 104.61M
Operating Income
$ 99.17M$ 8.96M$ -234.19M$ 134.25M
Net Non Operating Interest Income Expense
$ -86.24M$ -86.24M$ -283.68M$ -60.40M
Other Income Expense
$ -35.09M$ -16.72M$ -4.39M$ 8.14M
Pretax Income
$ -227.43M$ -245.80M$ -2.16B$ 63.08M
Tax Provision
$ 19.05M$ 683.00K$ -17.09M$ 15.76M
Earnings From Equity Interest Net Of Tax
----
Net Income Common Stockholders
$ -246.49M$ -246.49M$ -2.15B$ 47.31M
Basic EPS
$ -0.64$ -0.65$ -6.30$ 0.23
Diluted EPS
$ -0.64$ -0.65$ -6.30$ 0.20
Basic Average Shares
$ 1.52B$ 379.86M$ 340.65M$ 207.26M
Diluted Average Shares
$ 1.52B$ 379.86M$ 340.65M$ 233.31M
Dividend Per Share
----
Total Operating Income As Reported
----
Reported Normalized Basic E P S
----
Reported Normalized Diluted E P S
----
Rent Expense Supplemental
----
Total Expenses
$ 397.61M$ 487.56M$ 874.50M$ 410.24M
Net Income From Continuing And Discontinued Operation
$ -246.49M$ -246.49M$ -2.15B$ 47.31M
Normalized Income
$ 84.99M$ -1.11M--
Interest Expense
----
EBIT
$ -225.65M$ -244.02M$ -2.23B$ 63.08M
EBITDA
$ -128.45M$ -146.82M$ -2.00B$ 97.81M
Currency in USD

Core Scientific Inc Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis